Women’s health clinical trials: breaking down barriers through decentralisation
Women tend to be harder to recruit for clinical trials due to socioeconomic factors. But decentralised study designs help ease…
By
Women tend to be harder to recruit for clinical trials due to socioeconomic factors. But decentralised study designs help ease…
ByThe AlzoSure Predict test has already received Breakthrough Device designation from the US FDA.
The CAPTIS device is designed to lessen the risk of stroke and other complications during catheter-based heart surgeries.
The trial data showed that patients reported significant quality-of-life improvements.
ECGenius comprises a 12-lead ECG, four blood pressure channels and 128 intracardiac channels.
The study will evaluate the safety and performance of the new balloon guide catheter to treat acute ischemic stroke.
The Guardant SHIELD assay showed high accuracy in identifying tumour tissue of origin.
Aphasia trigger and the inherent challenge of standardising behavioural treatments are key considerations in clinical trials.
By